Ulcerative Colitis Clinical Trials in Wyoming, Michigan

5 studies are recruiting for ulcerative colitis in Wyoming, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

   Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 month…

   Stage

   Phase 4

   Ages

   18 to 80

   Site

   Gastroenterology Associates of Western Michigan, P.L.C., Wyoming, Michigan

   Locations

   101 in total

   Run by

   Takeda

   See if you can join NCT06581328 on ClinicalTrials.gov

2. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

   This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 286 weeks including: * 40…

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming, Michigan

   Locations

   55 in total

   Run by

   Sanofi

   See if you can join NCT07185009 on ClinicalTrials.gov

3. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

   This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 35 weeks wi…

   Stage

   Phase 3

   Ages

   16 to 80

   Site

   Gastroenterology Associates of Western Michigan - Site Number: 8400060, Wyoming, Michigan

   Locations

   219 in total

   Run by

   Sanofi

   See if you can join NCT07184996 on ClinicalTrials.gov

4. A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

   The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC).

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Gastroenterology Associates of Western Michigan, P.L.C., Wyoming, Michigan

   Locations

   207 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT06598943 on ClinicalTrials.gov

5. A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

   This is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Ulcerative Colitis. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Ulcerative Colitis. The total study duration…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Investigational Site Number: 8400012, Wyoming, Michigan

   Locations

   67 in total

   Run by

   Sanofi

   See if you can join NCT06975722 on ClinicalTrials.gov